Latest Period
Q2 2026
Security Snapshot
Nautilus Biotechnology, Inc. - Common Stock, par value $0.0001 per share (NAUT) Institutional Ownership
CUSIP: 63909J108
13F Institutional Holders and Ownership History from Q2 2021 to Q2 2026
Institutions Reporting
92
Shares (Excl. Options)
50,144,546
Price
$1.87
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- NAUT on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 50,144,546
- Total 13F value
- $93,710,071
- Portfolio coverage rank
- 0%
- Share change
- -4,183,763
- Value change
- -$13,129,860
- Number of holders
- 92
- Shares outstanding
- 127,848,473
- SEC-reported price per share
- $1.87
- Insider filing price
- $1.87
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- NAUT - Nautilus Biotechnology, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 63909J108.
- 92 institutions reported positions in Q2 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 79 to 92 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $210,829,144 to $93,710,071.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 92 institutions filings for Q2 2026.
Security key
63909J108
Latest holder period
Q2 2026
13F holders
92
13D/G owners
4
CIK / CUSIP context first
Open Q2 2026 holders
NAUT full holder history
Nautilus Biotechnology, Inc. SEC filings
Nautilus Biotechnology, Inc. company facts
Nautilus Biotechnology, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 63909J108:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
NAUT
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Mallick Parag | 18% | +1.2% | $48,724,008 | +$633,960 | 22,557,411 | +1.3% | Parag Mallick | 02 Mar 2026 |
| Patel Sujal M | 16% | +3.8% | $45,899,924 | +$2,056,823 | 21,249,965 | +4.7% | Sujal Patel | 02 Mar 2026 |
| PERCEPTIVE ADVISORS LLC | 9.1% | -10% | $21,755,975 | -$2,208,287 | 11,634,211 | -9.2% | Perceptive Advisors LLC | 30 Jun 2026 |
| AH Bio Fund II, L.P. | 7.1% | -28% | $24,470,246 | -$9,695,330 | 9,063,054 | -28% | Marc L. Andreessen | 26 Jun 2026 |
As of 30 Jun 2026, 92 institutional investors reported holding 50,144,546 shares of Nautilus Biotechnology, Inc. - Common Stock, par value $0.0001 per share (NAUT). This represents 39% of the company’s total 127,848,473 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
37%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 9.1% | 11,634,211 | -7.6% | 0.34% | $21,755,974 |
| a16z Capital Management, L.L.C. | 7.1% | 9,063,054 | -49% | 0.12% | $16,947,911 |
| Cercano Management LLC | 5.6% | 7,172,985 | 0% | 1.8% | $13,413,482 |
| BlackRock, Inc. | 2.1% | 2,687,226 | +1332% | 0% | $5,025,113 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2% | 2,549,979 | +0.17% | 0% | $4,768,461 |
| Comprehensive Financial Management LLC | 1.7% | 2,207,619 | 0% | 0.14% | $4,128,248 |
| CITADEL ADVISORS LLC | 1.5% | 1,896,192 | 0% | $3,545,879 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.99% | 1,265,535 | +110% | 0% | $2,367,107 |
| ACADIAN ASSET MANAGEMENT LLC | 0.83% | 1,055,461 | +42% | 0% | $1,965,000 |
| Clearstead Advisors, LLC | 0.7% | 892,787 | -62% | 0.02% | $1,669,512 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.7% | 890,949 | 0% | $1,666,074 | |
| SENTINEL TRUST CO LBA | 0.59% | 750,000 | 0% | 0.12% | $1,402,000 |
| BARCLAYS PLC | 0.57% | 725,321 | +889% | 0% | $1,356,352 |
| RENAISSANCE TECHNOLOGIES LLC | 0.54% | 690,514 | +160% | 0% | $1,291,261 |
| JPMORGAN CHASE & CO | 0.48% | 614,177 | 0% | $1,099,377 | |
| STATE STREET CORP | 0.44% | 559,508 | +159% | 0% | $1,046,280 |
| DIMENSIONAL FUND ADVISORS LP | 0.37% | 475,844 | +45% | 0% | $889,254 |
| NORTHERN TRUST CORP | 0.3% | 381,234 | +256% | 0% | $712,908 |
| HRT FINANCIAL LP | 0.28% | 361,073 | +453% | 0% | $675,000 |
| VANGUARD FIDUCIARY TRUST CO | 0.28% | 353,093 | +16% | 0% | $660,284 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.26% | 337,748 | 0% | $631,589 | |
| MARSHALL WACE, LLP | 0.21% | 265,582 | -17% | 0% | $496,639 |
| Qube Research & Technologies Ltd | 0.2% | 257,346 | +223% | 0% | $481,237 |
| GOLDMAN SACHS GROUP INC | 0.2% | 252,751 | -35% | 0% | $472,644 |
| HILLMAN CO | 0.16% | 200,000 | 0% | 0.13% | $374,000 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
21
Latest
Q2 2026
Rows shown
1-21 of 21
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 50,144,546 | $93,710,071 | -$13,129,860 | $1.87 | 92 |
| 2026 Q1 | 54,340,611 | $210,829,144 | +$12,540,346 | $3.88 | 79 |
| 2025 Q4 | 58,296,547 | $113,673,004 | +$1,369,133 | $1.95 | 66 |
| 2025 Q3 | 57,899,311 | $48,912,774 | -$1,403,087 | $0.84 | 65 |
| 2025 Q2 | 59,755,012 | $43,314,600 | -$2,449,905 | $0.72 | 67 |
| 2025 Q1 | 62,775,437 | $54,045,644 | -$1,026,756 | $0.86 | 86 |
| 2024 Q4 | 63,869,661 | $107,299,374 | -$821,201 | $1.68 | 86 |
| 2024 Q3 | 64,190,100 | $182,943,834 | +$1,290,455 | $2.85 | 81 |
| 2024 Q2 | 63,999,578 | $149,759,950 | +$1,608,547 | $2.34 | 75 |
| 2024 Q1 | 63,240,413 | $185,925,873 | -$499,885 | $2.94 | 70 |
| 2023 Q4 | 63,424,716 | $189,647,655 | +$5,847,645 | $2.99 | 74 |
| 2023 Q3 | 45,082,721 | $142,463,072 | +$769,963 | $3.16 | 74 |
| 2023 Q2 | 44,814,450 | $173,427,573 | +$1,498,150 | $3.87 | 74 |
| 2023 Q1 | 44,499,314 | $123,255,982 | -$1,802,223 | $2.77 | 72 |
| 2022 Q4 | 46,081,461 | $82,942,228 | -$2,657,044 | $1.80 | 78 |
| 2022 Q3 | 56,460,432 | $119,696,429 | -$2,490,160 | $2.12 | 77 |
| 2022 Q2 | 57,502,356 | $154,669,821 | +$297,442 | $2.69 | 80 |
| 2022 Q1 | 56,024,124 | $243,509,430 | -$20,551,922 | $4.34 | 79 |
| 2021 Q4 | 41,913,282 | $217,115,889 | +$1,259,255 | $5.18 | 77 |
| 2021 Q3 | 40,974,903 | $245,092,558 | +$9,814,243 | $6.14 | 68 |
| 2021 Q2 | 33,010,619 | $331,901,744 | +$331,901,478 | $10.10 | 55 |